Pharmaceutical Industry Lupin Partners With LG Life Sciences
Lupin has signed a strategic distribution agreement with LG Life Sciences, to launch Insulin Glargine, a novel insulin analogue under the brand name Basugine.
Mumbai/India – According to the agreement, Lupin would be responsible for marketing and sales of Basugine in India. Currently, Lupin ranks second in the conventional insulin market and grew more than the market at 10.82 per cent in April 2014, while the market grew at 8 per cent. Lupin is amongst the fastest growing players in the OAD (Oral Anti-Diabetes Drugs) market.